Russell Investments Group
CGEM icon

Russell Investments Group’s Cullinan Oncology CGEM Stock Holding History

Russell Investments Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.7K Sell
4,272
-20,137
-82% -$259K ﹤0.01% 3259
2025
Q4 		$253K Buy
24,409
+20,137
+471% +$182K ﹤0.01% 2754
2025
Q3 		$25.3K Sell
4,272
-36,714
-90% -$269K ﹤0.01% 3526
2025
Q2 		$309K Buy
40,986
+11,623
+40% +$93.4K ﹤0.01% 2511
2025
Q1 		$222K Buy
+29,363
New +$282K ﹤0.01% 2561
2024
Q3 		– Sell
-34,293
Closed -$598K – 3706
2024
Q2 		$598K Buy
+34,293
New +$730K ﹤0.01% 2140
2024
Q1 		– Sell
-2,300
Closed -$23.4K – 3314
2023
Q4 		$23.4K Buy
+2,300
New +$20.4K ﹤0.01% 2726
2023
Q3 		– Sell
-21,784
Closed -$234K – 3539
2023
Q2 		$234K Buy
21,784
+19,598
+897% +$208K ﹤0.01% 2438
2023
Q1 		$22.4K Buy
+2,186
New +$24.1K ﹤0.01% 2800

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return